Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet?

Clin Infect Dis. 2006 Jul 1;43(1):103-5. doi: 10.1086/504878. Epub 2006 May 26.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • Dideoxynucleosides / adverse effects*
  • Drug Hypersensitivity / genetics*
  • Drug Hypersensitivity / prevention & control
  • Genetic Testing*
  • HLA-B Antigens / genetics*
  • Humans
  • Pharmacogenetics

Substances

  • Anti-HIV Agents
  • Dideoxynucleosides
  • HLA-B Antigens
  • HLA-B*57:01 antigen
  • abacavir